About GutID
Built on sequencing our team helped invent
Next-generation sequencing is how the microbiome was discovered. GutID is made by Intus Bio, a microbiome sequencing company in Meriden, Connecticut.
Developed and manufactured by
The people who made it
Two of the people behind the first commercial next-generation sequencer went on to design Titan-1. A third turns what it measures into practice.
Mark Driscoll, PhD
Chief Scientific Officer and Co-Founder, Intus Bio. Co-inventor of Titan-1™.
At 454 Life Sciences, Mark led global product and project management on the GS-20 — the first commercial next-generation sequencing instrument, and the machine that started the NGS era.
He leads the Intus Bio team building the scientific case for the technology — the published work establishing strain-level resolution, and how it compares with 16S-only and shotgun methods, across 30+ peer-reviewed publications and growing.
Daniel Fasulo, PhD
Head of Bioinformatics. Co-inventor of Titan-1™.
Dan was Associate Director of Bioinformatics at 454 Life Sciences, working on that same instrument.
He built the classification platform behind Titan-1™ — the part that assigns identity from the complete ribosomal operon rather than matching short markers against a catalog, which is what improves detection of novel and poorly represented organisms.
Elena Panzeri, MSc
Microbiome and Personalized Nutrition Practitioner. Scientific and Microbiome Innovation Consultant.
Elena is a scientist and practitioner specializing in the microbiome, nutrigenetics, epigenetics, metabolomics and precision nutrition. At GutID she applies microbiome analysis to personalized interventions across diet, supplementation and lifestyle.
She has led educational workshops and works in science communication on microbial diversity, longevity microbiomics and gut-brain mechanisms.
Why it is different
The method is ours
Titan-1™ is not one trick. A proprietary lysis and extraction step we manufacture ourselves opens organisms conventional methods struggle to recover, while keeping the DNA intact across the more fragile ones — forceful enough for the tough, gentle enough for the rest. A patented amplicon spans the complete 16S–ITS–23S ribosomal region. And our own AI-driven bioinformatics platform assigns identity from that full operon. Species- and strain-level resolution comes from the combination, not from any single step.
Patented, and ISO 9001 certified
Titan-1™ is a patented platform, run in an ISO 9001 certified operation. The method is documented, repeatable, and the same for every sample.
Answerable to clinicians
The work is published and the interpretation is written down. Clinicians can see what a measure tells them, how much confidence it warrants, and what it should change.
Ready when you are
Order a test, or set up a practice account.
Shop the tests →Register a practice account →